Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma PURPOSE: Two phase II studies were ...
Please provide your email address to receive an email when new articles are posted on . In this video, Lori Muffly, MD, MS, discussed a presentation from the Society of Hematologic Oncology Annual ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The addition of nelarabine to a standard hyper-CVAD regimen demonstrated durable overall response ...
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...
FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...
TCT 241: Clinical Characteristics and Outcomes of Impella-Supported High-Risk PCI in Patients Turned Down for Coronary Artery Bypass Graft Surgery: Insights from the cVAD PROTECT III Study Receive the ...
Still, adding more Impella pumps is a big part of Abiomed's bottom line. The company booked $32.2 million in revenue during its fiscal 2012 third quarter, up 18% from the same period the previous year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results